Inverness closes Cholestech buy:
This article was originally published in Clinica
Executive Summary
Inverness Medical Innovations (IMI) has completed its acquisition of the heart disease diagnostics specialist Cholestech in a stock-for-stock merger. The deal, which closed September 12, saw one Cholestech share exchanged for 0.43642 IMI shares. The deal was completed through the merger of one of IMI's wholly-owned subsidiaries with and into Hayward, California-based Cholestech. This is IMI's fifth purchase of the year; it most recently closed a deal for protein-based diagnostics specialist Matritech (see Clinica No 1271, p 3).
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.